Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Bath & Body Works, Inc.
Report date May 14, 2020 · Filed May 18, 2020
Section 16 reporting ended · disclosed 2020-05-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 27,338 |
Reported balance
After 2020-05-14 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2020-05-14 · Grant · Acquired 3,629 · Balance 27,338 F1: This award converts to common stock on a 1-for-1 basis. F2: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F3: Total holdings include shares acquired in exempt dividend reinvestment transactions. |
Filing footnotes · ownership attribution and instrument terms
F1: This award converts to common stock on a 1-for-1 basis.
F2: The shares of phantom stock become payable upon the reporting person's termination of service as a director.
F3: Total holdings include shares acquired in exempt dividend reinvestment transactions.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2020 Filed May 18, 2020 22:51 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantPhantom Stock · Derivative | 3,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-007979 · doc4.xml · derivative · entry 1 GEE GORDON · CIK 0001117041 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,338 Underlying: Common Stock, $0.50 par value · 3,629 shares Expires not disclosed F1 · derivative.exercise_price: This award converts to common stock on a 1-for-1 basis. F2 · derivative.exercise_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F3 · balance_after: Total holdings include shares acquired in exempt dividend reinvestment transactions. Read SEC document |
| March 28, 2019 Filed Apr 3, 2019 00:49 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantPhantom Stock · Derivative | 4,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-006224 · doc4.xml · derivative · entry 1 GEE GORDON · CIK 0001117041 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,303 Underlying: Common Stock, $0.50 par value · 4,811 shares Expires not disclosed F1 · derivative.exercise_price: This award converts to common stock on a 1-for-1 basis. F2 · derivative.exercise_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F3 · balance_after: Total holdings include shares acquired in exempt dividend reinvestment transactions. Read SEC document |
| March 21, 2018 Filed Mar 23, 2018 20:48 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantPhantom Stock · Derivative | 3,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-006645 · doc4.xml · derivative · entry 1 GEE GORDON · CIK 0001117041 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,334 Underlying: Common Stock, $0.50 par value · 3,410 shares Expires not disclosed F1 · derivative.exercise_price: This award converts to common stock on a 1-for-1 basis. F2 · derivative.exercise_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F3 · balance_after: Total holdings include shares acquired in exempt dividend reinvestment transactions. Read SEC document |
| March 31, 2017 Filed Apr 4, 2017 20:38 UTC | Bath & Body Works, Inc. LB · Entity 4091 | GrantPhantom Stock · Derivative | 2,854 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-007416 · doc4.xml · derivative · entry 1 GEE GORDON · CIK 0001117041 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,270 Underlying: Common Stock, $0.50 par value · 2,854 shares Expires not disclosed F1 · derivative.exercise_price: This award converts to common stock on a 1-for-1 basis. F2 · derivative.exercise_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F2 · derivative.expiration_date: The shares of phantom stock become payable upon the reporting person's termination of service as a director. F3 · balance_after: Total holdings include shares acquired in exempt dividend reinvestment transactions. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.